Otitis

Published on 06/06/2015 by admin

Filed under Pediatrics

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1855 times

31 Otitis

Otitis is defined as inflammation of the ear. Otitis media is inflammation of the middle ear, and otitis externa is inflammation of the outer ear and canal.

To first review basic anatomy, the ear is divided into three parts: the outer, middle, and inner ear. The outer ear consists of the auricle and ear canal up to the tympanic membrane (TM). The middle ear is bounded by the TM and the round window. The middle ear contains three bones that conduct sound—the malleus, the incus, and the stapes—and the Eustachian (pharyngotympanic) tube that connects the middle ear cavity to the pharynx. The inner ear contains the cochlea and semicircular canals (Figure 31-1).

Otitis Externa

Acute otitis externa (AOE), more commonly known as “swimmer’s ear,” is a condition of diffuse inflammation in the external auditory canal. The estimated yearly incidence is 1 in 100 to 250, and although costs have not been reported, they are likely considerable because the condition is so widespread.

Clinical Presentation

The patient presents with symptoms that are rapid in onset over days, including ear pain and pruritus, or “fullness” in the ear canal. Some families may also note redness, discharge, or even hearing loss if the condition has progressed sufficiently to block the ear canal.

The peak incidence of AOE occurs in children age 7 to 12 years. There has often been significant water exposure, and even if swimming pool water quality is high, causative organisms are generally still present. Some parents or patients may admit to canal trauma with cotton swabs or bobby pins when questioned on history.

In AOE, the physical examination is critical in diagnosis. Debris and cerumen must be cleared from the canal to ensure accurate otoscopy of the TM as well as to improve the ability of topical treatment to reach the area of infection. The hallmark sign of AOE is tenderness of the tragus or the pinna when manipulated. The clinician will see diffuse edema and erythema of the canal, possibly with otorrhea or other debris present (Figure 31-2). The TM may be erythematous, but this should not imply a definite diagnosis of otitis media. On pneumatic otoscopy, if there is normal movement of the TM without visible effusion, the erythema may be attributed to the AOE.

On differential diagnosis, other conditions that should be considered include otitis media with perforation, malignant otitis externa (necrotizing osteomyelitis), furunculosis, contact otitis of the ear canal (largely from nickel jewelry, but also topical antimicrobials, chemicals, plastics, and so on), and other generalized dermatologic conditions occurring in or around the ear canal.

Evaluation and Management

After the diagnosis of AOE has been made by history and physical examination, it is rare that further evaluation is warranted. Only if an initial presentation has not resolved with prescribed therapy should a culture be taken for bacterial and fungal identification. On suspicion that the patient could have malignant otitis externa, further imaging may be needed to clarify the diagnosis. This serious condition should be suspected if the patient has a high temperature or necrotic tissue, facial paresis, meningeal signs, or mastoid involvement.

Appropriate management of AOE includes treating the causative organism as well as the debilitating pain. Topical therapy should be the initial treatment for uncomplicated AOE, and systemic antibiotics are not warranted. No studies have reliably proven one topical agent to work better than another. Acetic acid (2.0%) and alcohol (90%-95% isopropyl) solutions work as well as antimicrobial drops to clear AOE; however, they may be irritating. Aminoglycosides and fluoroquinolones with and without steroids have been approved for treatment of AOE. Examples include combinations of ciprofloxacin and hydrocortisone or dexamethasone, the combination of neomycin, polymyxin B, and hydrocortisone, and ofloxacin.

Because none of these treatments has proven best, an important consideration is the side effect profile. With a perforated TM or a myringotomy tube present, agents with ototoxicity should be strictly avoided, including the aminoglycosides and alcohol-based products. Contact dermatitis commonly (5%-15% prevalence) occurs with aminoglycoside otic drops. Other factors to consider include cost and compliance. Currently, fluoroquinolone drops are much more costly than other preparations. Conversely, patients may be more compliant with the fluoroquinolone drops because they need only be administered twice daily compared with four times daily for aminoglycosides.

Systemic oral antimicrobials should be reserved for cases in which cellulitis is extending onto the external ear or face, necrotizing disease is discovered, a concomitant middle ear infection exists, or the patient has an underlying immunodeficiency that makes him or her more susceptible to disease progression.

If a fungal cause of AOE is suspected, the clinician will see white strands with or without black or white fungal balls. Mild fungal infections respond to acid or alcohol solutions, but more advanced infections may require a topical antifungal such as clotrimazole.

Appropriate drug delivery is paramount. If the canal debris cannot be cleared by the physician, a wick should be inserted so that topical treatment can reach the infection. The parents should be instructed on how to correctly administer drops with the patient lying down, drops applied until filling the ear canal, and the patient maintaining this position for 3 to 5 minutes. Children should avoid submerging their heads underwater for 7 to 10 days while being treated, and beneficial effects from treatment should be seen in 48 to 72 hours.

Pain should be evaluated and treated for each patient. Most patients will benefit simply from a nonsteroidal antiinflammatory drug (NSAID). Topical anesthetic agents such as benzocaine may be used, but the relief they provide may mask progression of disease.

Otitis Media

Otitis media is inflammation in the middle ear. Otitis media should be further delineated into either acute otitis media (AOM) or otitis media with effusion (OME). Both of these conditions are extremely prevalent; AOM is the most common illness pediatricians encounter and the most common reason for antibiotic prescriptions in children. OME is reported to occur in 90% of children before they reach school age.

Clinical Presentation

Acute Otitis Media

AOM is common in children of all ages. Parents will generally bring their child to the office with a complaint of pain, pulling on the ear, fever, and/or ear drainage. Before examining a child for AOM or OME, the physician must be comfortable with otoscopy of the normal ear and TM. The most common TM landmarks visible on a normal examination include the umbo and handle of the malleus, the shadow of the incus, and the cone of light reflex (Figure 31-3). On pneumatic otoscopy, the physician should appreciate the back-and-forth motion of the normal TM with gentle squeezing and releasing of the bulb.

A physical examination is required to determine the presence of a middle ear effusion (MEE). On inspection of the TM, it may be bulging, or an air-fluid level or bubble will be visible. The normal landmarks may be obscured and the light-reflex absent or distorted. The movement of the TM will be decreased or absent. Sometimes purulent material will be seen behind the TM (Figure 31-4). In the case of a perforated TM, the perforation itself may be visible or the canal may be filled with debris, fluid, or exudate. Erythema of the TM alone is nondiagnostic because the TM may be red in many other conditions, including AOE and OME and during a child’s crying. In children, lack of cooperation often impedes a complete examination. Treatment recommendations for a nondiagnostic, uncertain examination are discussed further below.

Evaluation and Management

The most recent clinical guidelines by the American Academy of Pediatrics (AAP) detail a certain diagnosis of AOM when there is a history of acute onset, signs of MEE, and signs or symptoms of middle ear inflammation such as severe otalgia or severe erythema. A certain diagnosis of OME is made if a MEE is visible but the other conditions are not present. If the TM cannot be visualized for any reason, a physician could consider tympanometry, if available, to determine the presence or absence of an effusion.

In almost all cases of AOM and OME, after a complete history and physical examination, further testing is not necessary. Rarely, a culture may be taken from a chronically draining ear or radiologic studies may be ordered if there is a suspicion of mastoiditis. In children with OME at risk for developmental disabilities, such as those with underlying developmental syndromes, hearing and language testing should be considered early in the course of disease. For otherwise healthy children with OME, any concern for developmental delay or hearing loss or the persistence of effusion for longer than 3 months should prompt testing.

Acute Otitis Media Treatment

The goals of treatment for AOM include relieving pain, eradicating infection, and preventing complications. Pain should be evaluated and treated in all patients either with an NSAID or acetaminophen. Topical anesthetic otic drops such as benzocaine may provide additional, brief pain relief.

In recent years, there has been a shift in the treatment recommendations for AOM from universal antibiotic use to include the option of observation before requiring antibiotics. Clinical research has shown that most children older than 2 years of age have spontaneous resolution of AOM without antibiotic therapy. There also appears to be no increased risk for complications such as mastoiditis with watchful waiting of older children. Importantly, the observation option helps to limit further emergence of resistant bacteria. The decision to observe or treat should be based on the child’s age, diagnostic certainty, and disease severity (Table 31-1). The treatment guidelines proposed by the New York Regional Otitis Project, the AAP, and the American Academy of Family Physicians recommend treatment differences based on age because severe complications are most common in infants and the youngest children.

Table 31-1 Criteria for Initial Antibiotic Treatment versus Observation in Children with Acute Otitis Media

Age Certain Diagnosis Uncertain Diagnosis
<6 months Antibiotic therapy Antibiotic therapy
6 months–2 years Antibiotic therapy Antibiotic if severe; observation option if not*
>2 years Antibiotic if severe; observation option if not* Observation option*

* Observation option is appropriate only when follow-up can be ensured within 48 to 72 hours and antibiotics started if symptoms persist or worsen. Nonsevere illness is defined as only mild otalgia and fever below 39°C. A history of acute symptom onset, middle ear effusion, and signs of middle ear inflammation make a certain diagnosis.

Modified Rosenfeld R: Observation option toolkit for acute otitis media. Int J Pediatr Otorhinolaryngol 58(1):1-8, 2001; New York Regional Otitis Project: Observation Option Toolkit for Acute Otitis Media. State of New York, Department of Health, Publication #4894, March 2002; and American Academy of Pediatrics Subcommittee on Management of Acute Otitis Media. Diagnosis and management of acute otitis media. Pediatrics 113(5):1451-1465, 2004.

In choosing antimicrobial therapy for AOM, amoxicillin is the antibiotic of choice even though a large percentage of S. pneumoniae are resistant. The mechanism of resistance is via a penicillin-binding protein that may be overcome by “high-dose” amoxicillin at 80 to 90 mg/kg/d in two divided doses. Even though half of all H. influenzae and all of M. catarrhalis are β-lactamase positive, more of these infections clear spontaneously than infections with S. pneumoniae. In patients with severe illness or recurrent AOM, a broader antibiotic should be used such as amoxicillin–clavulanate, a third-generation cephalosporin, or azithromycin in a penicillin-allergic patient. The length of treatment has traditionally been 10 days, but newer studies conclude that 5 days of treatment may be sufficient for older children. Intramuscular ceftriaxone may also be used if the patient cannot tolerate oral antibiotics or has failed initial treatment.

If a perforation of the TM exists or a draining tympanostomy tube is present, only a topical antimicrobial agent is necessary. Possible choices include ofloxacin or ciprofloxacin with dexamethasone. Decongestants, antihistamines, and oral steroids have not shown any clinical benefit and should not be recommended for AOM treatment.

Referral to an otolaryngologist should be considered if the child has had AOM four times in 6 months or six times in 1 year, there is worsening of symptoms despite antibiotic therapy, or there is any complication of AOM. Tympanostomy tubes may be considered for recurrent AOM because they have been shown to decrease the number of episodes of AOM per year.

Suggested Readings